Bee Gee's "stayin' Alive" song would come to mind, were it not all so sad.
90 day survival rates in a PRE-DETERMINED SUB-GROUP (that one was falsely argued for so long) showing these mortality improvements are longer-term. What a criminal shame Remestemcel-L is not out there halving mortality rates in critically ill C-19 ARDS patients (the majority of C-19 deaths) because of an all mighty cock up by the DSMB and NIH in MSB's C-19 ARDS trial - when you have a quickly changing disease cohort on of the DSMB's jobs is to redefine the trial parameters accordingly.
Oh the humanity.
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT, page-34
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.010(1.10%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 90.5¢ | $4.638M | 5.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 152669 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 51069 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |